All In Biotech

Drug Trial Radar · NCT02193087

Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)

A Randomized, Double Blind, Phase 2 Study to Assess the Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Adults

Last checked: Nov 19, 2026Latest source record: Jul 18, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 1,002 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,002

Actual

Start

Aug 6, 2014

Primary completion

May 19, 2015

Study completion May 19, 2015

Sponsor

Lead sponsor
TakedaTakeda (TAK)
Sponsor type
Industry
First posted
Jul 17, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Basic science
Who can join
All sexes, from 18 years, up to 49 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the equivalence of the lyophilized formulation of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) compared with the liquid formulation of TDV.

Conditions

  • Dengue Fever

Interventions

  • TDV Liquid Formulation 1Drug

    TDV Liquid Formulation 1 for subcutaneous injection

  • TDV Liquid Formulation 2Drug

    TDV Liquid Formulation 2 for subcutaneous injection

  • TDV IDT LyophilizedDrug

    TDV Lyophilized Formulation for subcutaneous injection

  • PlaceboDrug

    TDV liquid formulation placebo-matching solution for subcutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Geometric Mean Titer (GMT) of Neutralizing Antibodies for Each of the Four Dengue Serotypes Comparing Group D To Groups A and B CombinedTime frame: Month 1

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Hope Research Institute

    Phoenix, Arizona

  • Anaheim Clinical Trials, LLC

    Anaheim, California

  • Clinical Research Atlanta

    Stockbridge, Georgia

  • Advanced Clinical Research

    Meridian, Idaho

  • Johnson County Clin-Trials

    Lenexa, Kansas

  • Clinical Research Center of Nevada

    Las Vegas, Nevada

  • Tekton Research

    Austin, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.